NetworkNewsBreaks Archive - Page 1914 of 1937

TuesdayNov 29, 2016 1:00 pm

NetworkNewsBreaks – FDA Grants PharmaCyte Biotech (PMCB) Pre-IND Meeting for Pancreatic Cancer Therapy; Shares Soar

PharmaCyte Biotech (OTCQB: PMCB) shares are up 46% mid-morning on news the company has been granted a Pre-Investigational New Drug (Pre-IND) meeting with the FDA’s Center for Biologics Evaluation and Research (CBER) regarding the company’s planned clinical trial for patients with locally advanced, inoperable pancreatic cancer (LAPC). The pre-IND meeting is the next step in PharmaCyte’s plans to advance its pancreatic cancer therapy into a clinical trial and eventual FDA approval. To view the full press release, visit: http://nnw.fm/fAD6W About PharmaCyte Biotech PharmaCyte Biotech a clinical stage biotechnology company developing therapies for cancer and diabetes based upon a proprietary cellulose-based…

TuesdayNov 29, 2016 10:57 am

NetworkNewsBreaks – eXp World Holdings’ (EXPI) Brokerage Division Warrants Analysis Update at Fundamental Research

After the release of its record financial results in the third quarter of 2016, eXp World Holdings (OTCQB: EXPI) was analyzed by Fundamental Research Corp. The independent research group updated its analysis with an increased fair value estimate and revenue forecast. “eXp Realty has remained the driving force behind the group’s increase throughout the last few months, as it is currently one of the fastest growing real estate brokerages on the U.S. market, having nearly tripled in size and operations since inception. The Agent-Owned Cloud Brokerage™ currently has more than 2,200 real estate professionals serving 41 states, the District of…

TuesdayNov 29, 2016 10:54 am

NetworkNewsBreaks – Agora Holdings, Inc.’s (AGHI) FRAME Increases Social Media Efficiencies

Agora Holdings (OTC: AGHI) recently introduced its FRAME social media management software for businesses. This new technology enables companies to dedicate less time to social media while still furthering their growth, resulting in a more cost-effective strategy. “In addition to a range of customer care tools, analytics, and reporting, the social media management software contributes hugely to an organization’s bottom line, saving it time and money. FRAME allows businesses to publish content that is not only relevant but also fits in perfectly with strategic objectives. FRAME is currently integrated with Twitter (NYSE: TWTR), Facebook (NASDAQ: FB), and Instagram, and it…

MondayNov 28, 2016 2:50 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on November 28, 2016

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: PZRX 143.37% – News: PRX-OTC receives Orphan Drug Designation EMGL 47.06% – News: Posts Q3 financial results, GAAP revenues increase 133% EPIX 31.93% – News: Secures $10 million term loan REPH 23.58%– News: Positive results from second phase III clinical trial for Meloxicam MRIC 17.92% – News: ClearPoint® will be exhibited at AES Annual Meeting December 2 - 6, 2016, in Houston STEM 11.79% – News: Merges with Microbot Medical; will begin trading on…

MondayNov 28, 2016 1:13 pm

NetworkNewsBreaks – Neovasc, Inc. (NVCN) Receives Regulatory Approval for TIARA II CE Mark Study

Neovasc (NASDAQ: NVCN) (TSX: NVC) says it has received both regulatory and ethics committee approval to initiate the Tiara™ Transcatheter Mitral Valve Replacement Study (TIARA II) in Italy. TIARA II is a 115-patient prospective clinical study evaluating the safety and performance of the Tiara™ Transcatheter Mitral Valve with the Tiara™ Transapical Delivery System (Tiara™). Following this approval, the first Italian TIARA II clinical study will begin before year end and the first enrollment early in the New Year. Approvals in additional geographies are expected in the first quarter of 2017. Data from this study is anticipated to be used to…

MondayNov 28, 2016 1:11 pm

NetworkNewsBreaks – Idera Pharmaceuticals (IDRA) Signs Exclusive License Agreement with Vivelix Pharmaceuticals for IMO-9200

Idera Pharmaceuticals (NASDAQ: IDRA) and Vivelix Pharmaceuticals Ltd. have entered into an exclusive license and collaboration agreement granting Vivelix worldwide rights to develop and market IMO-9200, an antagonist of TLR 7,8 and 9, for non-malignant gastrointestinal disorders. Per the agreement, Idera will receive an upfront fee of $15 million. In addition, Idera will be eligible for future IMO-9200-related development, regulatory and sales milestone payments totaling up to $140 million, as well as escalating royalties of global net sales. Idera is also responsible for developing potential back-up compounds to IMO-9200 if requested by and at Vivelix’s expense. As it relates to…

MondayNov 28, 2016 1:07 pm

NetworkNewsBreaks – KFit Group Acquires Groupon (GRPN) Malaysia

KFit Group this morning announced its acquisition of Groupon Malaysia (NASDAQ: GRPN) to build online-to-offline (O2O) commerce in Southeast Asia. The transaction follows KFit Group's acquisition of Groupon's Indonesia business in August and the rapid growth of its new Fave platform. Groupon Malaysia will transition to Fave in early 2017, expanding Fave to cover restaurants, beauty, wellness, gyms, studios, hotels, holidays, leisure, entertainment and professional services. "We are excited to have KFit Group steer Groupon Malaysia to even greater heights. With Joel's experience in leading Groupon Asia Pacific in the past, we are confident that KFit Group will be able…

MondayNov 28, 2016 1:04 pm

NetworkNewsBreaks – GainClients, Inc. (GCLT) GCard Connects Real Estate Agents and Mobile Users

Bridging the communication gap between mobile users and real estate agents, GainClients (OTC: GCLT) uses modern digital technologies to offer its new GCard service. “The GCard is a web and mobile real estate networking system for industry professionals and consumers. The platform brings together the entire real estate industry via a text or email invitation and helps real estate professionals serve clients by allowing them to share a range of important real estate data. The GCard has been designed to help build relationships among realtors and consumers by capitalizing on the ongoing transition toward mobile solutions.” To view the full…

MondayNov 28, 2016 1:02 pm

NetworkNewsBreaks – National Waste Management Holdings, Inc.’s (NWMH) Acquisition Strategy Drives Q3 Growth

National Waste Management (OTC: NWMH) recently announced 269% revenue growth for the third quarter of 2016. Signs point to this being a reflection of revenue growth through acquiring new businesses. “This financial growth is largely attributable to the company’s aggressive acquisition strategy, highlighted through the 2015 acquisitions of Waste Recovery Enterprises and Gateway Rolloff Services. National Waste leveraged this strategy once again in June of this year, when it acquired Sivart Services, a roll-off and compactor business located in Worchester, New York, in an effort to expand its geographic footprint in the northeast while supporting additional revenue growth.” To view…

MondayNov 28, 2016 1:01 pm

NetworkNewsBreaks – Moxian, Inc. (MOXC) Plans for Continued Growth in 2016

The future brightens for Moxian (NASDAQ: MOXC) as the China-based provider of social media marketing and promotion platforms takes steps toward reaching its goal to expand the company in 2016. “Driving more sales and expanding to Beijing are not the only highlights from 2016. Recently, MOXC uplisted to the Nasdaq Capital Market. The release of this news was accompanied by that of Moxian completing a best efforts public offering of over 2.5 million shares of its common stock at a public offering price of $4 per share. This uplisting will play a key role in widening MOXC’s visibility within the…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsBreaks